|
1
|
Guo L, Lu X, Zheng L, Liu X and Hu M:
Association of long non-coding RNA HOTAIR polymorphisms with
cervical cancer risk in a Chinese population. PLoS One.
11:e01600392016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hang D, Yin Y, Han J, Jiang J, Ma H, Xie
S, Feng X, Zhang K, Hu Z, Shen H, et al: Analysis of human
papillomavirus 16 variants and risk for cervical cancer in Chinese
population. Virology. 488:156–161. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Liang Y, Sun R, Li L, Yuan F, Liang W,
Wang L, Nie X, Chen P, Zhang L and Gao L: A functional polymorphism
in the promoter of MiR-143/145 is associated with the risk of
cervical squamous cell carcinoma in Chinese women: A case-control
study. Medicine (Baltimore). 94:e12892015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Li H, Wu X and Cheng X: Advances in
diagnosis and treatment of metastatic cervical cancer. J Gynecol
Oncol. 27:e432016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jing H, Qu X, Liu L and Xia H: A novel
long noncoding RNA (lncRNA), LL22NC03-N64E9. 1, promotes the
proliferation of lung cancer cells and is a potential prognostic
molecular biomarker for lung cancer. Med Sci Monit. 24:43172018.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Xiao B, Huang Z, Zhou R, Zhang J and Yu B:
The prognostic value of expression of the long noncoding RNA
(lncRNA) small nucleolar RNA Host Gene 1 (SNHG1) in patients with
solid malignant tumors: A systematic review and meta-analysis. Med
Sci Monit. 24:5462–5472. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hao S, Yao L, Huang J, He H, Yang F, Di Y,
Jin C and Fu D: Genome-wide analysis identified a number of
dysregulated long noncoding RNA (lncRNA) in human pancreatic ductal
adenocarcinoma. Technol Cancer Res Treat. 17:15330346177484292018.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Fu XM, Guo W, Li N, Liu HZ, Liu J, Qiu SQ,
Zhang Q, Wang LC, Li F and Li CL: The expression and function of
long noncoding RNA lncRNA-ATB in papillary thyroid cancer. Eur Rev
Med Pharmacol Sci. 21:3239–3246. 2017.PubMed/NCBI
|
|
9
|
Misawa A, Takayama K, Urano T and Inoue S:
Androgen-induced long noncoding RNA (lncRNA) SOCS2-AS1 promotes
cell growth and inhibits apoptosis in prostate cancer cells. J Biol
Chem. 291:17861–17880. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen T, Xie W, Xie L, Sun Y, Zhang Y, Shen
Z, Sha N, Xu H, Wu Z, Hu H and Wu C: Expression of long noncoding
RNA lncRNA-n336928 is correlated with tumor stage and grade and
overall survival in bladder cancer. Biochem Biophys Res Commun.
468:666–670. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
He Y, Luo Y, Liang B, Ye L, Lu G and He W:
Potential applications of MEG3 in cancer diagnosis and prognosis.
Oncotarget. 8:73282–73295. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ghafouri-Fard S and Taheri M: Maternally
expressed gene 3 (MEG3): A tumor suppressor long non coding RNA.
Biomed Pharmacother. 118:1091292019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sun KX, Wu DD, Chen S, Zhao Y and Zong ZH:
lncRNA MEG3 inhibit endometrial carcinoma tumorigenesis and
progression through PI3K pathway. Apoptosis. 22:1543–1552. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang J, Xu W, He Y, Xia Q and Liu S:
lncRNA MEG3 impacts proliferation, invasion, and migration of
ovarian cancer cells through regulating PTEN. Inflamm Res.
67:927–936. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Cui X, Jing X, Long C, Tian J and Zhu J:
Long noncoding RNA MEG3, a potential novel biomarker to predict the
clinical outcome of cancer patients: A meta-analysis. Oncotarget.
8:19049–19056. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Pecorelli S: Revised FIGO staging for
carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol
Obstet. 105:103–104. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Migdalska-Sęk M, Karowicz-Bilińska A,
Pastuszak-Lewandoska D, Czarnecka KH, Nawrot E,
Domańska-Senderowska D, Kiszałkiewicz J and Brzeziańska-Lasota E:
Assessment of the frequency of genetic alterations (LOH/MSI) in
patients with intraepithelial cervical lesions with HPV infection:
A pilot study. Med Oncol. 33:512016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Peng L, Yuan X, Jiang B, Tang Z and Li GC:
lncRNAs: Key players and novel insights into cervical cancer.
Tumour Biol. 37:2779–2788. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
González-Quintana V, Palma-Berré L,
Campos-Parra AD, López-Urrutia E, Peralta-Zaragoza O, Vazquez-Romo
R and Pérez-Plasencia C: MicroRNAs are involved in cervical cancer
development, progression, clinical outcome and improvement
treatment response (Review). Oncol Rep. 35:3–12. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Landoni F, Colombo A, Milani R, Placa F,
Zanagnolo V and Mangioni C: Randomized study between radical
surgery and radiotherapy for the treatment of stage IB-IIA cervical
cancer: 20-year update. J Gynecol Oncol. 28:e342017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kong TW, Piao X, Chang SJ, Paek J, Lee Y,
Lee EJ and Ryu HS: A predictive model for parametrial invasion in
patients with FIGO stage IB cervical cancer: Individualized
approach for primary treatment. Int J Gynecol Cancer. 26:184–191.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Qin R, Chen Z, Ding Y, Hao J, Hu J and Guo
F: Long non-coding RNA MEG3 inhibits the proliferation of cervical
carcinoma cells through the induction of cell cycle arrest and
apoptosis. Neoplasma. 60:486–492. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chen X and Qu J: Long non-coding RNA MEG3
suppresses survival, migration, and invasion of cervical cancer.
Onco Targets Ther. 11:4999–5007. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Xiu YL, Sun KX, Chen X, Chen S, Zhao Y,
Guo QG and Zong ZH: Upregulation of the lncRNA Meg3 induces
autophagy to inhibit tumorigenesis and progression of epithelial
ovarian carcinoma by regulating activity of ATG3. Oncotarget.
8:31714–31725. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang W, He W, Shi Y, Zhao J, Liu S, Zhang
F, Yang J, Xie C and Zhang Y: Aberrant TIMELESS expression is
associated with poor clinical survival and lymph node metastasis in
early-stage cervical carcinoma. Int J Oncol. 50:173–184. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Rofstad EK, Huang R, Galappathi K,
Andersen LM, Wegner CS, Hauge A, Gaustad JV and Simonsen TG:
Functional intratumoral lymphatics in patient-derived xenograft
models of squamous cell carcinoma of the uterine cervix:
Implications for lymph node metastasis. Oncotarget. 7:56986–56997.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang J, Yao T, Wang Y, Yu J, Liu Y and
Lin Z: Long noncoding RNA MEG3 is downregulated in cervical cancer
and affects cell proliferation and apoptosis by regulating miR-21.
Cancer Biol Ther. 17:104–113. 2016. View Article : Google Scholar : PubMed/NCBI
|
